Simpson Thacher is representing Blackstone in connection with its acquisition of the entire equity stake in AYUMI Pharmaceutical. The acquisition will mark Blackstone’s first control private…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Michael Patrini
…
This content is for Standard 1 Year members only. LoginJoin Now